Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".
Feiten S, Chakupurakal G, Feustel HP, Maasberg M, Otremba B, Ehscheidt P, Hensel M, Hansen R, Weide R. Feiten S, et al. Among authors: chakupurakal g. Support Care Cancer. 2020 Jan;28(1):3-4. doi: 10.1007/s00520-019-05126-z. Epub 2019 Nov 8. Support Care Cancer. 2020. PMID: 31701271 No abstract available.
Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality--a single institution experience.
Chakupurakal G, Leitzke S, Langerbeins P, Schiller J, Schneider PM, Holtick U, Shimabukuro-Vornhagen A, Theurich S, Chemnitz J, Hallek M, von Bergwelt-Baildon M, Scheid C. Chakupurakal G, et al. Ann Hematol. 2015 Oct;94(10):1717-25. doi: 10.1007/s00277-015-2449-1. Epub 2015 Aug 12. Ann Hematol. 2015. PMID: 26259502
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
Holtick U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, Leitzke S, Burst A, Hallek M, von Bergwelt-Baildon M, Scheid C, Chemnitz JM. Holtick U, et al. Among authors: chakupurakal g. Eur J Haematol. 2016 May;96(5):475-82. doi: 10.1111/ejh.12615. Epub 2015 Aug 25. Eur J Haematol. 2016. PMID: 26132980
Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies.
Pflug N, Chakupurakal G, Fink AM, Robrecht S, Herling M, Cramer P, Holtick U, Theurich S, Schetelig J, Fischer K, Ritgen M, Scheid C, Eichhorst B, Dreger P, Hallek M, von Bergwelt-Baildon M. Pflug N, et al. Among authors: chakupurakal g. Hemasphere. 2021 Nov 12;5(12):e664. doi: 10.1097/HS9.0000000000000664. eCollection 2021 Dec. Hemasphere. 2021. PMID: 34881358 Free PMC article. No abstract available.
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.
Theurich S, Fischmann H, Chakupurakal G, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Rothe A, Scheid C, Hallek M, Skoetz N, von Bergwelt-Baildon M. Theurich S, et al. Among authors: chakupurakal g. Crit Rev Oncol Hematol. 2013 Oct;88(1):178-86. doi: 10.1016/j.critrevonc.2013.03.009. Epub 2013 Apr 2. Crit Rev Oncol Hematol. 2013. PMID: 23561334 Review.
30 results